Resultats de la cerca - Kapiteijn, Ellen
- Mostrar 1 - 20 resultats de 55
- Anar a la pàgina següent
-
1
-
2
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer per van Holstein, Yara, Kapiteijn, Ellen, Bastiaannet, Esther, van den Bos, Frederiek, Portielje, Johanneke, de Glas, Nienke A.
Publicat 2019Text -
3
The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review per van Opijnen, Mark P., Dirven, Linda, Coremans, Ida E.M., Taphoorn, Martin J.B., Kapiteijn, Ellen H.W.
Publicat 2019Text -
4
Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies per Burgmans, Mark C., de Leede, Eleonora M., Martini, Christian H., Kapiteijn, Ellen, Vahrmeijer, Alexander L., van Erkel, Arian R.
Publicat 2015Text -
5
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer per Aydemirli, Mehtap Derya, Corver, Willem, Beuk, Ruben, Roepman, Paul, Solleveld-Westerink, Nienke, van Wezel, Tom, Kapiteijn, Ellen, Morreau, Hans
Publicat 2019Text -
6
-
7
Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper per Bastiaannet, Esther, Battisti, Nicolò, Loh, Kah Poh, de Glas, Nienke, Soto-Perez-de-Celis, Enrique, Baldini, Capucine, Kapiteijn, Ellen, Lichtman, Stuart
Publicat 2018Text -
8
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants per Spagnolo, Francesco, Dalmasso, Bruna, Tanda, Enrica, Potrony, Miriam, Puig, Susana, van Doorn, Remco, Kapiteijn, Ellen, Queirolo, Paola, Helgadottir, Hildur, Ghiorzo, Paola
Publicat 2021Text -
9
Intermittent versus continuous systemic therapy as treatment for unresectable metastatic colorectal cancer per Frouws, Martine A., Claassen, Yvette, Breugom, Anne J, Bastiaannet, Esther, Mocellin, Simone, van de Velde, Cornelis JH, Liefers, Gerrit‐Jan, Kapiteijn, Ellen
Publicat 2016Text -
10
Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer per Claassen, Yvette, Breugom, Anne J, Frouws, Martine A., Bastiaannet, Esther, Sabajo, Charissa R, Liefers, Gerrit‐Jan, van de Velde, Cornelis JH, Kapiteijn, Ellen
Publicat 2016Text -
11
-
12
-
13
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients per van Erp, Nielka P., van Herpen, Carla M., de Wit, Djoeke, Willemsen, Annelieke, Burger, David M., Huitema, Alwin D. R., Kapiteijn, Ellen, ter Heine, Rob
Publicat 2016Text -
14
Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer per Claassen, Yvette HM, van der Valk, Maxime JM, Breugom, Anne J, Frouws, Martine A., Bastiaannet, Esther, Liefers, Gerrit‐Jan, van de Velde, Cornelis JH, Kapiteijn, Ellen
Publicat 2018Text -
15
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations per Helgadottir, Hildur, Ghiorzo, Paola, van Doorn, Remco, Puig, Susana, Levin, Max, Kefford, Richard, Lauss, Martin, Queirolo, Paola, Pastorino, Lorenza, Kapiteijn, Ellen, Potrony, Miriam, Carrera, Cristina, Olsson, Håkan, Höiom, Veronica, Jönsson, Göran
Publicat 2020Text -
16
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver per de Leede, Eleonora M., Burgmans, Mark C., Martini, Christian H., Tijl, Fred G. J., van Erkel, Arian R., Vuyk, Jaap, Kapiteijn, Ellen, Verhoef, Cornelis, van de Velde, Cornelis J. H., Vahrmeijer, Alexander L.
Publicat 2016Text -
17
Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion wit... per de Leede, Eleonora M., Burgmans, Mark C., Meijer, T. Susanna, Martini, Christian H., Tijl, Fred G. J., Vuyk, Jaap, van Erkel, Arian R., van der Velde, Cornelis J. H., Kapiteijn, Ellen, Vahrmeijer, Alexander L.
Publicat 2017Text -
18
Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic P... per de Leede, Eleonora M., Burgmans, Mark C., Meijer, T. Susanna, Martini, Christian H., Tijl, Fred G. J., Vuyk, Jaap, van Erkel, Arian R., van der Velde, Cornelis J. H., Kapiteijn, Ellen, Vahrmeijer, Alexander L.
Publicat 2017Text -
19
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltrat... per Meijer, T. Susanna, Burgmans, Mark C., Fiocco, Marta, de Geus-Oei, Lioe-Fee, Kapiteijn, Ellen, de Leede, Eleonora M., Martini, Christian H., van der Meer, Rutger W., Tijl, Fred G. J., Vahrmeijer, Alexander L.
Publicat 2019Text -
20
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer per Piperno-Neumann, Sophie, Piulats, Jose Maria, Goebeler, Matthias, Galloway, Iain, Lugowska, Iwona, Becker, Jürgen C., Vihinen, Pia, Van Calster, Joachim, Hadjistilianou, Theodora, Proença, Rui, Caminal, Jose Maria, Rogasik, Muriel, Blay, Jean-Yves, Kapiteijn, Ellen
Publicat 2019Text